Mindbloom Releases First America on Psychedelics Report

Medically reviewed by 
Published on 
September 26, 2023
Updated on 
Findings confirm psychedelic medicine is moving into the mainstream of mental health — and more people have tried it than you think. Download the full report here.

Five years ago, many Americans had never heard of psychedelic medicine – and if they had, the phrase conjured up caricatures from too many bad movies. Psychedelics were vilified by the War on Drugs, and the idea that they could become a mainstream mental health treatment seemed like science fiction. 

Today, that view has been turned on its head, and psychedelic medicine is at the center of the mental health conversation. At Mindbloom, we hear stories every day from clients whose lives have been positively transformed by psychedelic medicine. We see representatives in Congress proposing legislation on psychedelic research, and we read about professional athletes using psychedelics to improve their mental health. 

With all this public discussion, we wanted to understand better what mental health challenges Americans are facing, and how they view psychedelic medicine. So we surveyed a nationally representative sample of people across the U.S., and the America on Psychedelics report released today presents a surprising – and encouraging – picture of Americans’ embrace of psychedelic medicine. 

Highlights include:

  • 58% of Americans are open to trying ketamine therapy or other psychedelic medicine
  • … and 25% would prefer ketamine therapy to antidepressants or talk therapy
  • Black Americans are 2x as likely as White Americans to have received psychedelic therapy
  • Millennials are 13x as likely as Gen X or Baby Boomers to have received ketamine therapy
  • Men are more than 2.5x as likely as women to have received ketamine therapy or other psychedelic medicine

The challenge of ending the mental health crisis is daunting, but the advancement of psychedelic medicine gives me hope. It’s clear from this report that people are ready and willing to explore psychedelics as powerful tools to improve their mental health, and against the backdrop of the mental health crisis, it’s no wonder why: last-generation mental health treatments aren’t getting the job done, and it has become impossible to ignore the mountain of studies demonstrating the remarkable effectiveness of ketamine, MDMA, psilocybin, and more.

Mindbloom is committed to expanding access to safe and effective psychedelic medicine – starting with at-home ketamine therapy, and the new pathways we’re launching for issues like grief, managing emotions, and rewiring habits. This treatment is transforming lives today, and, with FDA approval of MDMA and psilocybin coming soon, the future of mental health care looks bright. 

Click here to view the full report, and please contact press@mindbloom.com with any inquiries.


This article is for informational purposes only and is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. If you are in a life-threatening situation, call the National Suicide Prevention Line at +1 (800) 273-8255, call 911, or go to the nearest emergency room.

Important FDA Safety Information

Ketamine is not FDA-approved for the treatment of depression or anxiety. Learn more about off-label uses here.

Side effects of ketamine treatment may include: altered sense of time, anxiety, blurred vision, diminished ability to see/hear/feel, dry mouth, elevated blood pressure or heart rate, elevated intraocular or intracranial pressure, excitability, loss of appetite, mental confusion, nausea/vomiting, nystagmus (rapid eye movements), restlessness, slurred speech, synesthesia (a mingling of the senses).

Do not proceed with ketamine treatment if any of the following apply to you:

  • Allergic to ketamine
  • Symptoms of psychosis or mania
  • Uncontrolled high blood pressure
  • CHF or other serious heart problem
  • Severe breathing problem
  • History of elevated intraocular or intracranial pressure
  • History of hyperthyroidism
  • Other serious medical illness
  • Pregnant, nursing, or trying to become pregnant

Ketamine has been reported to produce issues including, but not limited to, those listed below. However, lasting adverse side-effects are rare when medical protocols are carefully followed.

While ketamine has not been shown to be physically addictive, it has been shown to cause moderate psychological dependency in some recreational users.

  • In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
  • Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders.
  • Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your MindBloom® clinician before proceeding with treatment.
  • The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents.

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

  • Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
  • Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
  • Continue to take antihypertensive medication as prescribed
  • Avoid hangovers or alcohol intake
  • Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
  • Ketamine treatment should never be conducted without a monitor present to ensure your safety